BIOMEA FUSION, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.65 USD | -6.91% |
|
-13.77% | -26.65% |
| 02/05 | Biomea Fusion, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 03/04 | North American Morning Briefing : Powell Awaited -2- | DJ |
Chart calendar Biomea Fusion, Inc.
a50ccef75135c.LDNu7cYQ78kIw8HcYRmwFJoB_MDi9FaiNRt4XN16Jw0.T0koufFol6c7uZmlKmrFRtZvsqaynSHqc3NOK4I5bldHSTiks3uZ-GSJqg~7ff00e89206830b3c39e93b048527d8e
Upcoming events on Biomea Fusion, Inc.
Past events on Biomea Fusion, Inc.
| 01/04/2024 06:30 pm | Q4 2023 Earnings Release |
| 14/03/2024 09:45 pm | Barclays Global Healthcare Conference |
| 06/03/2024 | Advanced Technologies and Treatments for Diabetes International Conference - Abstract Number : 722 |
| 06/03/2024 | Advanced Technologies and Treatments for Diabetes International Conference - Abstract Number : 751 |
| 06/03/2024 | Advanced Technologies and Treatments for Diabetes International Conference - Abstract Number : 101 |
| 09/01/2024 09:45 pm | JPMorgan Healthcare Conference |
| 11/12/2023 07:30 am | American Society of Hematology Meeting - BMF-219 |
| 10/12/2023 07:00 am | American Society of Hematology Meeting - COVALENT-103 |
| 09/12/2023 09:00 am | Insulin Resistance, Diabetes and Cardiovascular Disease World Congress |
| 08/12/2023 08:00 am | Insulin Resistance Diabetes and Cardiovascular Disease World Congress |
| 07/12/2023 08:30 pm | Insulin Resistance, Diabetes and Cardiovascular Disease World Congress |
| 31/10/2023 01:31 am | Q3 2023 Earnings Release |
| 07/09/2023 06:52 pm | Wells Fargo Healthcare Conference |
| 01/08/2023 01:31 am | Q2 2023 Earnings Release |
| 26/06/2023 06:00 pm | American Diabetes Association Scientific Session |
| 25/06/2023 06:00 am | American Diabetes Association Scientific Session - KOL |
| 25/06/2023 12:00 am | American Diabetes Association Scientific Conference |
| 23/06/2023 | American Diabetes Association Meeting |
| 14/06/2023 10:30 pm | Annual General Meeting |
| 02/05/2023 03:30 pm | H.C. Wainwright BioConnect Investor Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -82,9 -68,2 -21.67% | -125 -121 -2.77% | -166 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -41,7 -40,1 -3.89% | -83,6 -73,7 -13.42% | -126 -121 -3.84% | -163 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -41,6 -40,6 -2.41% | -81,8 -80,3 -1.86% | -117 -113 -3.9% | -158 |
|
Net income Million USD | Released Forecast Spread | -5,32 | -41,6 -40,1 -3.63% | -81,8 -72,7 -12.56% | -117 -113 -3.73% | -159 |
|
EPS USD | Released Forecast Spread | -0,50 | -1,74 -1,68 -3.42% | -2,80 -2,57 -8.81% | -3,44 -3,29 -4.51% | -4,22 |
| Announcement Date | 12/04/21 | 28/02/22 | 28/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -17,3 -17,0 -1.79% | -23,3 -18,6 -25.32% | -26,1 -4,15 -528.8% | -29,7 -26,8 -10.96% | -27,3 -30,5 10.58% | -30,7 -30,5 -0.66% | -36,9 -32,9 -12.16% | -39,8 | -42,8 | -45,3 | ||||
|
EBIT Million USD | Released Forecast Spread | -16,4 -15,2 -8.04% | -17,5 -17,8 1.94% | -23,5 -19,5 -20.51% | -26,3 -14,3 -84.34% | -30,0 -25,3 -18.93% | -27,7 -29,8 7.25% | -31,1 -30,2 -3.11% | -37,3 -32,6 -14.55% | -37,3 -32,5 -14.86% | -40,9 | -40,8 | -41,7 | -40,0 | -41,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -16,4 -15,7 -3.95% | -17,3 -18,0 4.06% | -22,9 -19,5 -17.61% | -25,3 -23,7 -7.01% | -29,1 -27,2 -6.66% | -24,9 -29,5 15.72% | -28,4 -29,3 2.89% | -34,9 -30,4 -14.6% | -34,9 -32,3 -7.89% | -38,7 | -39,1 | -39,3 | -40,0 | -41,5 |
|
Net income Million USD | Released Forecast Spread | -16,4 -14,9 -9.9% | -17,3 -17,8 2.96% | -22,9 -19,2 -18.95% | -25,3 -16,1 -57.32% | -29,1 -25,1 -15.65% | -24,9 -29,7 16.18% | -28,4 -29,4 3.37% | -34,9 -30,6 -14.11% | -34,9 -32,2 -8.43% | -38,6 | -39,2 | -40,7 | -40,0 | -41,5 |
|
EPS USD | Released Forecast Spread | -0,56 -0,53 -6.35% | -0,59 -0,60 2.13% | -0,78 -0,64 -21.17% | -0,86 -0,59 -46.59% | -0,98 -0,81 -21.49% | -0,70 -0,86 18.6% | -0,80 -0,82 2.54% | -0,98 -0,84 -16.02% | -0,98 -0,92 -7.1% | -1,08 | -1,05 | -1,04 | -1,09 | -1,13 |
| Announcement Date | 16/05/22 | 01/08/22 | 07/11/22 | 28/03/23 | 02/05/23 | 31/07/23 | 30/10/23 | 28/03/24 | 01/04/24 | - | - | - | - | - |
More events
Past sector events for Biomea Fusion, Inc.
| 10/05/2024 | HUMACYTE, INC.: Q1 2024 Earnings Release |
| 10/05/2024 | NOVAVAX, INC.: Q1 2024 Earnings Release |
| 10/05/2024 | TAKARA BIO INC.: Q4 2023 Earnings Release |
| 10/05/2024 | CHABIOTECH CO.,LTD.: Q1 2024 Earnings Release (Projected) |
| 10/05/2024 01:35 am | BIOHAVEN LTD.: Q1 2024 Earnings Release |
| 10/05/2024 01:35 am | OMNIAB, INC.: Q1 2024 Earnings Release |
| 10/05/2024 01:35 am | 4D MOLECULAR THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 09/05/2024 05:30 pm | CG ONCOLOGY, INC.: Q1 2024 Earnings Release |
| 09/05/2024 05:30 pm | DISC MEDICINE, INC.: Q1 2024 Earnings Release |
| 09/05/2024 05:30 pm | VERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BMEA Stock
- Calendar Biomea Fusion, Inc.